Optimizing treatment of epilepsy during pregnancy

Neurology

Volumn 67, Issue 12 SUPPL. 4, 2006, Pages

  Kälviäinen, Reetta ^a   Tomson, Torbjörn ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; VALPROIC ACID;

BIRTH DEFECT; CONCEPTION; COUNSELING; DRUG WITHDRAWAL; EPILEPSY; HUMAN; MONOTHERAPY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 33845702258     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.12_suppl_4.s59     Document Type: Review

References (34)

1. Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia 2004;45:1171-1175.
2. Adab N, Kini U, Vinten J, et al. The long term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-1583.
3. Van den Bergh BR, Mulder EJ, Mennes M, Glover V. Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobehav Rev 2005;29:237-258.
4. EURAP report May 2005. http://www.eurapinternational.com/about/library. html
5. Commission on Genetics, Pregnancy and the Child, International League against Epilepsy. Guidelines for the care of women of child-bearing age with epilepsy. Epilepsia 1993;34:588-589.
6. Perucca E. Overtreatment in epilepsy: adverse consequences and mechanisms. Epilepsy Res 2002:25-33.
7. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;45:739-746.
8. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-158
9. Vajda FJ, O'Brien TJ, Hitchcock A, et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian Register of Anti-epileptic Drugs in Pregnancy. J Clin Neurosci 2004;11:854-858
10. Artama M, Auvinen A, Raudaskoski T, Isojärvi I, Isojärvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005;64:1874-1878.
11. Morrow JI, Russell A, Gutherie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-198.
12. Wide K, Winbladt B, Källen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based study. Acta Paediatr 2004;93:174-176
13. Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Antiepileptic Drug Pregnancy Registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005;64:961-965
14. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62:28-32.
15. Eriksson K, Viinikainen K, Monkkonen A, et al. Children exposed to valproate in utero - population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 2005;65:189-200.
16. Bardy AH. Incidence of seizures during pregnancy, labor and puerperium in epileptic women: a prospective study. Acta Neurol Scand 1987;75:356-360.
17. Gjerde IO, Strandjord RE, Ulstein M. The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand 1988;78:198-205.
18. Tomson T, Lindbom U, Ekqvist B, Sundqvist A. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin. Epilepsia 1994;35:122-130.
19. The EURAP Study Group. Seizure control and treatment in pregnancy. Observations from the EURAP Epilepsy Pregnancy Registry. Neurology 2006;66:353-360.
20. Schmidt D. The effect of pregnancy on the natural history of epilepsy: a review of the literature. In: Janz D, Dam M, Bossi L, Helge H, Richens A, Schmidt D, eds. Epilepsy, Pregnancy, and the Child. New York: Raven Press, 1982:3-14.
21. Teramo K, Hiilesmaa VK. Pregnancy and fetal complications in epileptic pregnancies. In: Janz D, Dam M, Bossi L, Helge H, Richens A, Schmidt D, eds. Epilepsy, pregnancy, and the child. New York: Raven Press, 1982:53-59.
22. Lopes-Cendes IE, Andermann E, Cendes L, Dansky L, Andermann F. Risk factors for changes in seizure frequency during pregnancy of epileptic women: a cohort study. Epilepsia 1992;33(suppl 3):57. Abstract.
23. Perucca E. Drug metabolism in pregnancy, infancy and childhood. Pharmacol Ther 1987;34:129-143.
24. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61(suppl 2):S35-42.
25. Battino D, Binelli S, Bossi L, et al., Changes in primidone/phenobarbital ratio during pregnancy and the puerperium. Clin Pharmacokinet 1984;9:252-260.
26. Yerby MS. Friel PN. McCormick K. Antiepileptic drug disposition during pregnancy. Neurology 1992;42(suppl 5):12-16.
27. Tomson T, Öhman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38:1039-1041.
28. Öhman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000;41:709-713.
29. Tran TA, Leppik IE, Blesi K, et al. Lamotrigine clearance during pregnancy. Neurology 2002;59:251-255.
30. Pennell PB, Newport DJ, Stowe ZN, et al. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 2004;62:292-295.
31. de Haan GJ, Edelbroek P, Segers J, et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 2004;63:571-573.
32. Pennell PB, Ritchie JC, Newport DJ, et al. Defining fetal exposure to lamotrigine. Epilepsia 2004;45(supp. 7):233. Abstract.
33. May TW, Korn-Merker E, Rambeck B. Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 2003;42:1023-1042
34. Hunt SJ, Morrow JI. Safety of antiepileptic drugs during pregnancy. Expert Opin Drug Saft 2005;4:869-877.